vs
Side-by-side financial comparison of Eos Energy Enterprises, Inc. (EOSE) and 4D Molecular Therapeutics, Inc. (FDMT). Click either name above to swap in a different company.
4D Molecular Therapeutics, Inc. is the larger business by last-quarter revenue ($85.1M vs $58.0M, roughly 1.5× Eos Energy Enterprises, Inc.). 4D Molecular Therapeutics, Inc. runs the higher net margin — 22.8% vs -207.7%, a 230.5% gap on every dollar of revenue. On growth, 4D Molecular Therapeutics, Inc. posted the faster year-over-year revenue change (8508900.0% vs 699.6%). 4D Molecular Therapeutics, Inc. produced more free cash flow last quarter ($28.5M vs $-75.2M).
Eos Energy Enterprises, Inc. is an energy storage solutions provider that designs, produces and deploys safe long-duration zinc-based battery systems. It serves utility, commercial, industrial and microgrid customers across North America, Europe and Asia, supporting grid stability and renewable energy integration.
4D Molecular Therapeutics is a clinical-stage biotechnology company specializing in the research and development of targeted adeno-associated virus (AAV) gene therapies. Its core product candidates address unmet medical needs in ophthalmology, cardiology, and pulmonary disease segments, serving global patient populations with rare and common hard-to-treat conditions.
EOSE vs FDMT — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $58.0M | $85.1M |
| Net Profit | $-120.5M | $19.4M |
| Gross Margin | -93.8% | — |
| Operating Margin | -140.1% | 17.3% |
| Net Margin | -207.7% | 22.8% |
| Revenue YoY | 699.6% | 8508900.0% |
| Net Profit YoY | 55.1% | 139.1% |
| EPS (diluted) | $-0.53 | $0.43 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $58.0M | $85.1M | ||
| Q3 25 | $30.5M | $90.0K | ||
| Q2 25 | $15.2M | $15.0K | ||
| Q1 25 | $10.5M | $14.0K | ||
| Q4 24 | $7.3M | $1.0K | ||
| Q3 24 | — | $3.0K | ||
| Q2 24 | — | $5.0K | ||
| Q1 24 | — | $28.0K |
| Q4 25 | $-120.5M | $19.4M | ||
| Q3 25 | $-641.4M | $-56.9M | ||
| Q2 25 | $-222.9M | $-54.7M | ||
| Q1 25 | $15.1M | $-48.0M | ||
| Q4 24 | $-268.1M | — | ||
| Q3 24 | — | $-43.8M | ||
| Q2 24 | — | $-35.0M | ||
| Q1 24 | — | $-32.4M |
| Q4 25 | -93.8% | — | ||
| Q3 25 | -111.2% | — | ||
| Q2 25 | -203.2% | — | ||
| Q1 25 | -234.7% | — | ||
| Q4 24 | -324.0% | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | -140.1% | 17.3% | ||
| Q3 25 | -200.6% | -67983.3% | ||
| Q2 25 | -419.1% | -396373.3% | ||
| Q1 25 | -506.2% | -383007.1% | ||
| Q4 24 | -712.8% | — | ||
| Q3 24 | — | -1704400.0% | ||
| Q2 24 | — | -849120.0% | ||
| Q1 24 | — | -136200.0% |
| Q4 25 | -207.7% | 22.8% | ||
| Q3 25 | -2102.1% | -63195.6% | ||
| Q2 25 | -1463.2% | -364386.7% | ||
| Q1 25 | 144.7% | -342657.1% | ||
| Q4 24 | -3696.7% | — | ||
| Q3 24 | — | -1461433.3% | ||
| Q2 24 | — | -699060.0% | ||
| Q1 24 | — | -115717.9% |
| Q4 25 | $-0.53 | $0.43 | ||
| Q3 25 | $-4.91 | $-1.01 | ||
| Q2 25 | $-1.05 | $-0.98 | ||
| Q1 25 | $-0.20 | $-0.86 | ||
| Q4 24 | $-2.30 | — | ||
| Q3 24 | — | $-0.79 | ||
| Q2 24 | — | $-0.63 | ||
| Q1 24 | — | $-0.66 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $568.0M | $402.7M |
| Total DebtLower is stronger | $813.3M | — |
| Stockholders' EquityBook value | $-2.2B | $505.7M |
| Total Assets | $885.2M | $566.7M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $568.0M | $402.7M | ||
| Q3 25 | $58.7M | $305.1M | ||
| Q2 25 | $120.2M | $293.2M | ||
| Q1 25 | $82.6M | $321.4M | ||
| Q4 24 | $74.3M | $424.9M | ||
| Q3 24 | — | $501.9M | ||
| Q2 24 | — | $541.9M | ||
| Q1 24 | — | $525.9M |
| Q4 25 | $813.3M | — | ||
| Q3 25 | $448.5M | — | ||
| Q2 25 | $445.3M | — | ||
| Q1 25 | $325.5M | — | ||
| Q4 24 | $316.9M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $-2.2B | $505.7M | ||
| Q3 25 | $-2.3B | $369.0M | ||
| Q2 25 | $-1.1B | $420.9M | ||
| Q1 25 | $-942.2M | $469.7M | ||
| Q4 24 | $-1.1B | $510.6M | ||
| Q3 24 | — | $552.9M | ||
| Q2 24 | — | $588.3M | ||
| Q1 24 | — | $600.6M |
| Q4 25 | $885.2M | $566.7M | ||
| Q3 25 | $328.2M | $424.0M | ||
| Q2 25 | $361.0M | $473.6M | ||
| Q1 25 | $263.3M | $515.7M | ||
| Q4 24 | $260.3M | $560.4M | ||
| Q3 24 | — | $604.0M | ||
| Q2 24 | — | $620.1M | ||
| Q1 24 | — | $629.9M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-50.3M | $28.6M |
| Free Cash FlowOCF − Capex | $-75.2M | $28.5M |
| FCF MarginFCF / Revenue | -129.7% | 33.5% |
| Capex IntensityCapex / Revenue | 43.1% | 0.1% |
| Cash ConversionOCF / Net Profit | — | 1.47× |
| TTM Free Cash FlowTrailing 4 quarters | $-265.0M | $-109.9M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-50.3M | $28.6M | ||
| Q3 25 | $-65.9M | $-46.5M | ||
| Q2 25 | $-66.1M | $-43.4M | ||
| Q1 25 | $-28.9M | $-47.8M | ||
| Q4 24 | $-42.7M | $-134.6M | ||
| Q3 24 | — | $-29.4M | ||
| Q2 24 | — | $-30.2M | ||
| Q1 24 | — | $-29.1M |
| Q4 25 | $-75.2M | $28.5M | ||
| Q3 25 | $-82.7M | $-46.6M | ||
| Q2 25 | $-73.2M | $-43.4M | ||
| Q1 25 | $-33.8M | $-48.4M | ||
| Q4 24 | $-55.8M | $-138.4M | ||
| Q3 24 | — | $-31.2M | ||
| Q2 24 | — | $-30.6M | ||
| Q1 24 | — | $-29.8M |
| Q4 25 | -129.7% | 33.5% | ||
| Q3 25 | -271.1% | -51765.6% | ||
| Q2 25 | -480.2% | -289620.0% | ||
| Q1 25 | -323.6% | -345635.7% | ||
| Q4 24 | -769.1% | -13837100.0% | ||
| Q3 24 | — | -1038966.7% | ||
| Q2 24 | — | -611840.0% | ||
| Q1 24 | — | -106421.4% |
| Q4 25 | 43.1% | 0.1% | ||
| Q3 25 | 55.2% | 101.1% | ||
| Q2 25 | 46.2% | 440.0% | ||
| Q1 25 | 47.0% | 4507.1% | ||
| Q4 24 | 180.6% | 378600.0% | ||
| Q3 24 | — | 59266.7% | ||
| Q2 24 | — | 6980.0% | ||
| Q1 24 | — | 2535.7% |
| Q4 25 | — | 1.47× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | -1.91× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
